Compare Lippo Karawaci Tbk. (LPKR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lippo Karawaci Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Lippo Karawaci Tbk. trades at Rp61 (market cap 4.32T, 78.75M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Lippo Karawaci Tbk. is far larger — about 41.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LPKR | SCPI | |
|---|---|---|
Market Cap | 4.32T | 104.4B |
Volume | 78.75M | — |
Lot | 787.51K | — |
Turnover | 4.81B | — |
Average Price | 61.05 | — |
Value | 4.81B | — |
Indicative Equilibrium Price | 61 | — |
Indicative Equilibrium Volume | 28.62K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lippo Karawaci Tbk.
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
